DocGo Inc. (DCGO) Income Statement

NASDAQ: DCGORevenue, profits, margins and EPS over 7 years.

DCGO 2025 at a glance

Fiscal year ended December 31, 2025 · U.S. dollars
Revenue−47.7%
$322.2M
2025 · hover or tap a bar for each year
2019: $48.3M2020: $94.1M (+94.8%)2021: $318.7M (+238.7%)2022: $440.5M (+38.2%)2023: $624.3M (+41.7%)2024: $616.6M (−1.2%)2025: $322.2M (−47.7%)
20192025
Gross profit−53.8%
$98.8M
2025 · hover or tap a bar for each year
2019: $13.2M2020: $31.3M (+137.7%)2021: $109.7M (+250.1%)2022: $154.7M (+41.0%)2023: $195.4M (+26.3%)2024: $213.6M (+9.3%)2025: $98.8M (−53.8%)
20192025
Operating income−410.8%
−$89.2M
2025 · hover or tap a bar for each year
2019: −$20.8M2020: −$14.8M2021: $15.4M2022: $21.8M (+42.2%)2023: $15.1M (−31.0%)2024: $28.7M (+90.6%)2025: −$89.2M (−410.8%)
20192025
Net income−1,012.4%
−$182.4M
2025 · hover or tap a bar for each year
2019: −$20.2M2020: −$14.4M2021: $23.7M2022: $34.6M (+45.7%)2023: $6.9M (−80.2%)2024: $20.0M (+191.5%)2025: −$182.4M (−1,012.4%)
20192025
EPS (diluted)−308.5%
−$2.21
2025 · hover or tap a bar for each year
2020: −$0.012021: $99.612022: $1.00 (−99.0%)2023: $0.44 (−56.0%)2024: $1.06 (+140.9%)2025: −$2.21 (−308.5%)
20192025
Net profit margin−59.9 pts
−56.6%
2025 · hover or tap a point for each year
2019: −41.8%2020: −15.3% (+26.6 pts)2021: 7.4% (+22.7 pts)2022: 7.9% (+0.4 pts)2023: 1.1% (−6.8 pts)2024: 3.2% (+2.1 pts)2025: −56.6% (−59.9 pts)
20192025

DCGO revenue and net income

RevenueNet incomeNet margin (right axis)

Where DCGO's revenue goes

2025
Revenue
$322.2M100.0%
Cost of revenue
−$223.4M−69.3%
Gross profit
$98.8M30.7%
Research & development
−$13.6M−4.2%
Sales, general & admin
−$158.7M−49.3%
Other operating expenses
−$15.7M−4.9%
Operating income
−$89.2M−27.7%
Interest & other expense
−$98.3M−30.5%
Income taxes
−$8.9M−2.8%
Net income
−$182.4M−56.6%

Each bar shows an amount and its share of revenue. DCGO kept −56.6% of revenue as net income.

DCGO profit margins

GrossOperatingNet

DCGO growth rates

to 2025
1 year3 years5 years10 years
Revenue−47.7%−9.9%+27.9%—
Gross profit−53.8%−13.9%+25.8%—
Operating income−410.8%———
Net income−1,012.4%———
EPS (diluted)−308.5%———

1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.

DCGO quarterly EPS vs estimates

Reported EPSAnalyst estimate

DocGo beat the analyst EPS estimate in 3 of the last 8 quarters. Next report: November 9, 2026 (estimate $-0.04).

DCGO income statement

DocGo Inc. annual income statement
2025202420232022202120202019
Revenue$322.2M$616.6M$624.3M$440.5M$318.7M$94.1M$48.3M
Cost of revenue$223.4M$403.0M$428.9M$285.8M$209.0M$62.7M$35.1M
Gross profit$98.8M$213.6M$195.4M$154.7M$109.7M$31.3M$13.2M
Research & development$13.6M$11.6M$10.9M$5.4M$3.3M$1.2M$1.2M
Sales, general & admin$158.7M$157.4M$153.0M$116.9M$83.6M$39.4M$28.5M
Total operating expenses$187.9M$184.9M$180.3M$132.9M$94.4M$46.1M$34.0M
Operating income−$89.2M$28.7M$15.1M$21.8M$15.4M−$14.8M−$20.8M
Interest income——$1.7M$762,685———
Interest expense$1.0M$2.2M$1.68T$762,685$763,030$204,632$717,321
Income before taxes−$187.5M$27.7M$16.3M$22.8M$19.8M−$14.6M−$21.2M
Income taxes$8.9M$14.4M$6.2M−$8.0M$615,697$167,443$47,032
Net income−$182.4M$20.0M$6.9M$34.6M$23.7M−$14.4M−$20.2M
EBITDA−$170.8M$45.6M$32.7M$33.3M$28.1M−$9.3M−$16.6M
EPS (diluted)−$2.21$1.06$0.44$1.00$99.61−$0.01—
Gross margin30.7%34.6%31.3%35.1%34.4%33.3%27.3%
Operating margin−27.7%4.7%2.4%5.0%4.8%−15.7%−43.0%
Net margin−56.6%3.2%1.1%7.9%7.4%−15.3%−41.8%

Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in DCGO's financial statements (latest annual report filed March 16, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.

DCGO financial results

In fiscal year 2025 (ended December 31, 2025), DocGo reported revenue of $322.2 million, down 47.7% from the year before. It had a net loss of $182.4 million, a net profit margin of −56.6%. Diluted earnings per share came to −$2.21. Over five years revenue grew at an average rate of 27.9% a year.

See the DCGO stock overview for the latest quote and news, or the DCGO chart for price history and technical indicators.

DCGO income statement FAQ

What is DocGo's annual revenue?

DocGo reported total revenue of $322.2 million for fiscal year 2025, which ended on December 31, 2025. That was down 47.7% from $616.6 million the previous year.

Is DocGo profitable?

No. DocGo reported a net loss of $182.4 million in fiscal 2025, a net profit margin of −56.6%; its operating margin was −27.7%.

What is DocGo's gross margin?

DocGo's gross margin was 30.7% in fiscal 2025: for every $100 of revenue, DocGo kept $31 after the direct cost of its products and services.

How much does DocGo spend on research and development?

DocGo spent $13.6 million on research and development in fiscal 2025, 4.2% of revenue.

How fast is DocGo growing?

Revenue grew 27.9% a year on average over the last five fiscal years, from $94.1 million to $322.2 million.

What are DocGo's earnings per share?

DocGo earned $-2.21 per diluted share in fiscal 2025, compared with $1.06 a year earlier.

When will DocGo report its next earnings?

DocGo is expected to report results for the quarter ending September 30, 2026 on November 9, 2026 after the market closes.

When does DocGo's fiscal year end?

DocGo's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on March 16, 2026.

Medical Care Facilities income statements